Capricor Therapeutics

211 articles about Capricor Therapeutics

• Capricor Therapeutics, Inc. Reports Second Quarter 2015 Business & Financial Highlights

  8/14/2015

• Capricor Therapeutics, Inc. To Hold Second Quarter 2015 Business Update And Financial Results Conference Call On August 13, 2015 At 4:30 P.M. EDT

  8/6/2015

• Capricor Therapeutics, Inc. Appoints Deborah Ascheim, M.D. As Chief Medical Officer

  8/4/2015

• Capricor Therapeutics, Inc. Appoints Houman Hemmati M.D., Ph.D. To Vice President Of Medical And Clinical Development For New Therapies

  6/17/2015

• Capricor Therapeutics, Inc. And CureDuchenne To Host Webinar On June 19, 2015 At 3:00 P.M. ET

  6/15/2015

• Capricor Therapeutics, Inc. Announces Receipt Of FDA Clearance For The Phase I/II Study Of CAP-1002 For The Treatment Of Duchenne Muscular Dystrophy Related Cardiomyopathy

  6/8/2015

• Capricor Therapeutics, Inc. To Participate In Two Upcoming Investor Conferences In June

  5/27/2015

• Capricor Therapeutics, Inc. Reports First Quarter 2015 Financial & Business Highlights

  5/13/2015

• Capricor Therapeutics, Inc. To Hold First Quarter 2015 Business Update And Financial Results Conference Call On May 12, 2015 At 4:30 P.M. EDT

  5/6/2015

• Capricor Therapeutics, Inc. Granted FDA Orphan Drug Designation For Allogeneic Cardiosphere-Derived Cells For The Treatment Of Duchenne Muscular Dystrophy

  4/22/2015

• Capricor Therapeutics, Inc. Completes Enrollment Of Initial Phase Of DYNAMIC Clinical Trial Of Cardiosphere-Derived Cell Therapy For Treatment Of Advanced Heart Failure

  4/8/2015

• CryoPort, Inc. Expands Logistics Support To Capricor Therapeutics, Inc.'s DYNAMIC Clinical Trial For Heart Failure

  4/7/2015

• Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To Treat Heart Failure

  3/31/2015

• Capricor Therapeutics, Inc. To Present At 3rd Annual Regen Med Investor Day On March 25, 2015 In New York

  3/23/2015

• Capricor Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial & Business Highlights

  3/19/2015

• Capricor Therapeutics, Inc. To Hold Fourth Quarter 2014 Business Update Conference Call On March 18, 2015 At 4:30 P.M. EDT

  3/12/2015

• Capricor Therapeutics, Inc. To Present At The 27th Annual ROTH Conference

  3/10/2015

• Capricor Therapeutics, Inc. Announces Uplisting To NASDAQ Capital Market

  3/5/2015

• Capricor Therapeutics, Inc. Announces Enrollment Of Its Phase II Clinical Trial For Cenderitide To Treat Heart Failure

  3/5/2015

• Capricor Therapeutics, Inc. Appoints Thomas Copmann, Ph.D. As Vice President Of Regulatory Affairs And Drug Development

  2/27/2015